4 Multiple Myeloma Clinical Trials in Santa Monica, CA (2026)

Q: How do I join a clinical trial in Santa Monica?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Santa Monica research site will contact you.

Recruiting Multiple Myeloma Studies in Santa Monica

NCT04638647Recruiting

Secukinumab Open Label Roll-over Extension Protocol

The purpose of this study is to assess long term safety in participants who have completed a Novartis trial with secukinumab, have been judged by the investigator to benefit from continued treatment w...

Santa Monica, CAPHASE41,000 participantsNovartis Pharmaceuticals

View Study Details

NCT06208150Recruiting

A Study Comparing Talquetamab Plus Pomalidomide, Talquetamab Plus Teclistamab, and Elotuzumab, Pomalidomide, and Dexamethasone or Pomalidomide, Bortezomib, and Dexamethasone in Participants With Relapsed or Refractory Myeloma Who Have Received an Anti-CD38 Antibody and Lenalidomide

The purpose of this study is to compare the effectiveness of either talquetamab plus pomalidomide (Tal-P) or talquetamab plus teclistamab (Tal-Tec) with elotuzumab, pomalidomide, and dexamethasone (EP...

Santa Monica, CAPHASE3795 participantsJanssen Research & Development, LLC

View Study Details

NCT07391657Recruiting

A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)

This is a randomised, multicentre, controlled, open-label, Phase III global study comparing the efficacy and safety of AZD0120 versus standard regimens (DKd \[daratumumab, carfilzomib, and dexamethaso...

Santa Monica, CAPHASE3508 participantsAstraZeneca

View Study Details

NCT07280013Recruiting

A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects

The main purpose of the study is to understand the safety and tolerability of cemsidomide when given along with elranatamab in subjects with relapsed or refractory multiple myeloma. The first part of...

Santa Monica, CAPHASE160 participantsC4 Therapeutics, Inc.

View Study Details

About Multiple Myeloma Clinical Trials in Santa Monica

Multiple myeloma is a cancer of plasma cells in the bone marrow that produce abnormal antibodies. It can cause bone damage, kidney problems, and immune deficiency. Treatments have advanced significantly with proteasome inhibitors, immunomodulatory drugs, and CAR-T cell therapy.

There are currently 4 multiple myeloma clinical trials recruiting participants in Santa Monica, CA. These studies are seeking a combined 2,363 participants. Research is being sponsored by Novartis Pharmaceuticals, Janssen Research & Development, LLC, AstraZeneca and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Multiple Myeloma Clinical Trials in Santa Monica — FAQ

Are there multiple myeloma clinical trials in Santa Monica?

Yes, there are 4 multiple myeloma clinical trials currently recruiting in Santa Monica, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Santa Monica?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Santa Monica research site will contact you about next steps.

Are clinical trials in Santa Monica free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Santa Monica studies also compensate for your time and travel.

What multiple myeloma treatments are being tested?

The 4 active trials in Santa Monica are testing new therapies including novel drugs, biologics, and treatment approaches for multiple myeloma.

Data updated July 18, 2026 from ClinicalTrials.gov